OncoSil Medical Limited

ASX (AUD): OncoSil Medical Limited (OSL)

Last Price

0.006

Today's Change

-0.001 (14.28%)

Day's Change

0.006 - 0.006

Trading Volume

7,224,475

Profile
OSL

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Nigel Lange Mr. Nigel Lange

Full Time Employees:  2 2

IPO Date:  2005-08-15 2005-08-15

CIK: 

ISIN:  AU000000OSL3 AU000000OSL3

CUSIP:  Q7133Q109 Q7133Q109

Beta:  0.94 0.94

Last Dividend:  0.00 0.00

Dcf Diff:  0.01 0.01

Dcf:  0.00 0.00

Description

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.

Address

15 Blue Street,
North Sydney, NSW 2060, AU

61 2 9223 3344

http://www.oncosil.com.au

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment